| Page 122 | Kisaco Research

Rapid diagnostics are transforming everyday veterinary practice, enabling earlier detection and faster decision-making. Changemakers explore the latest advances in point-of-care tools, their role in improving outcomes, and the challenges of validation, adoption, and integration into workflows.

  • Validation – generating clinical evidence to support regulatory approval and vet adoption
  • Integration – embedding diagnostics into workflows for scale and commercial uptake
Moderator

Author:

Joe Harvey

Head of Animal Health
S&P Global

Joe Harvey

Head of Animal Health
S&P Global
Panellists

Author:

Richard Mellanby

Global Head of Medical Innovation and Strategy
IDEXX

Richard Mellanby

Global Head of Medical Innovation and Strategy
IDEXX

Veterinary associations recommend regular parasite control and diagnostics to prevent transmission. However, parasiticides face growing scrutiny over environmental and health concerns. With resistance increasing, changemakers are developing innovative solutions, ranging from new treatments to advanced diagnostics and targeted delivery, ensuring long-term protection for animals and humans.

  • Market differentiation – demonstrating value of novel products in a crowded market
  • Adoption hurdles – balancing efficacy, cost, and stewardship to drive uptake
Moderator

Author:

Claire Fowler

SVP Head of Global Strategic Marketing Animal Health,
Boehringer Ingelheim

After completing a degree in Veterinary Medicine at Cambridge University in 2002, her first professional experience was working in clinical veterinary practice before joining Boehringer Ingelheim in 2005. She subsequently completed an MBA at London Business School.

 

In Boehringer Ingelheim she has held positions at a local, regional and global level across business management, marketing and technical functions, mainly in Animal Health. This includes senior leadership roles such as the responsibility for the Boehringer Ingelheim Italian animal health subsidiary, and most recently for the overall commercial performance of the region encompassing Europe and Canada.  She also spent some time in Consumer Health Care as Category lead in global marketing.

 

Claire was appointed Head of Global Strategic Marketing in January 2025 and became a member of the Executive Committee of the Animal Health Business Unit at Boehringer.

Claire Fowler

SVP Head of Global Strategic Marketing Animal Health,
Boehringer Ingelheim

After completing a degree in Veterinary Medicine at Cambridge University in 2002, her first professional experience was working in clinical veterinary practice before joining Boehringer Ingelheim in 2005. She subsequently completed an MBA at London Business School.

 

In Boehringer Ingelheim she has held positions at a local, regional and global level across business management, marketing and technical functions, mainly in Animal Health. This includes senior leadership roles such as the responsibility for the Boehringer Ingelheim Italian animal health subsidiary, and most recently for the overall commercial performance of the region encompassing Europe and Canada.  She also spent some time in Consumer Health Care as Category lead in global marketing.

 

Claire was appointed Head of Global Strategic Marketing in January 2025 and became a member of the Executive Committee of the Animal Health Business Unit at Boehringer.

Advances in genetics and genomics are enabling faster progress in productivity, welfare, and disease resistance across livestock species. Changemakers highlight the changemakers applying genomic selection, gene editing, and advanced breeding strategies to improve animal health outcomes and productivity.

  • Regulatory pathways – navigating approval and acceptance of genomic technologies
  • Market adoption – demonstrating value to farmers and integrating innovation into breeding programs
Panellists

Author:

Dr Eve Hanks

Chief Executive Officer & Founder
MI:RNA Diagnostics

Dr Eve Hanks

Chief Executive Officer & Founder
MI:RNA Diagnostics

Author:

Owen Willems

Global Director R&D and Innovation
Hendrix Genetics

Owen Willems

Global Director R&D and Innovation
Hendrix Genetics

Nutrition-based therapies are redefining companion animal care, offering evidence-driven approaches to manage metabolic, inflammatory, and chronic conditions. With advances moving from research to practice, changemakers at the forefront of science and product development explore the opportunities and hurdles that will shape clinical validation, adoption, and long-term impact.

  • Clinical validation – generating evidence to secure veterinary confidence and consumer trust
  • Market adoption – positioning nutrition as a credible option to treat chronic disease
Moderator

Author:

Julie Lawless

President
Lawless Strategic Communications

Julie Lawless

President
Lawless Strategic Communications
Panellists

Author:

Rosa Carbonell

President
FEDIAF

Rosa Carbonell

President
FEDIAF

Cell and gene therapies are redefining the possibilities of veterinary medicine offering the potential to repair, replace, and restore biological function. With the first approvals expected as early as 2026, changemakers at the forefront of research and commercialisation explore the opportunities and hurdles that will define their path to clinical adoption.

  • Clinical adoption – building veterinary trust and integrating into practice workflows
  • Distribution – ensuring stability, scalability, and accessibility
Panellists

Author:

Linda Black

CEO
Gallant Therapeutics

Linda Black

CEO
Gallant Therapeutics

Author:

Thomas Koch

Founder, CEO & CSO
eQcell Inc

Thomas Koch

Founder, CEO & CSO
eQcell Inc

Author:

Julia Loew

Chief Commercial Officer
MWI Animal Health

Julia Loew

Chief Commercial Officer
MWI Animal Health

Artificial intelligence can play a vital role by enabling predictive analytics to help farmers anticipate productivity changes and prevent health issues before they escalate. Hear from the changemakers applying data-driven insights to deliver measurable health and productivity gains across livestock systems.

  • Demonstrating ROI – building the evidence base to drive farmer adoption
  • Data – overcoming the challenge of dispersed datasets from farms, labs and clinics
  • Route to market – integrating AI tools into existing farm management systems
Panellists

Author:

Paul Horwood

UK Head of Farm
IVC Evidensia

Paul Horwood

UK Head of Farm
IVC Evidensia

Author:

Robert Hyde

Co-Founder and CTO
Vet Vision AI

Robert Hyde

Co-Founder and CTO
Vet Vision AI

Winners will be announced across the following categories

  • Best in Class across Biopharma, Nutrition, Diagnostics and Technology
    Best in Show – Judges Award
  • Best in Show – Audience Award
  • Calan Smith Innovation Award

Author:

Niamh Gallagher

Program Director - AHNTI
Kisaco Research

Niamh Gallagher

Program Director - AHNTI
Kisaco Research

Bringing innovation to market means navigating complex and often fragmented regulatory pathways. This panel explores the regulatory hurdles that shape timelines, costs, and strategic choices, highlighting the global differences that influence market access. Panellists will also consider whether greater harmonisation across regions is possible, or even desirable, and what that could mean for innovators.

Moderator

Author:

Chris Boyle

Senior Managing Associate
Sidley Austin LLP

Chris Boyle

Senior Managing Associate
Sidley Austin LLP
Panellists

Author:

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Author:

Roxanne Feller

Secretary General
Animal Health Europe

Roxanne Feller

Secretary General
Animal Health Europe

A sneak peek into cutting‑edge research and innovations driving next‑generation biopharma — from human health breakthroughs to translational applications in animal health. Explore novel compounds, delivery technologies and cross‑species strategies accelerating Animal Health

Author:

Rob Kelly

SVP, Global Marketing & Commercial Leader EURAM
MSD Animal Health

Rob Kelly

SVP, Global Marketing & Commercial Leader EURAM
MSD Animal Health